UNSPSC 51361801: Dexmedetomidine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51361801

Definition

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67VB76HONO, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)-, (r)- but generally known as dexmedetomidine, which bears US NIH Compound Identifier 60612. European Medicines Agency schedules Dexmedetomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07037MIG.

Read the full definition

The term DEXMEDETOMIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules dexmedetomidine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule dexmedetomidine under HS 29332990 and SITC 51573. As of Q4 2014, DEXMEDETOMIDINE remains the US FDA Preferred Term for this commodity. Dexmedetomidine bears US NLM identifiers UMLS ID C0113293 and NCI Concept Code C47479. SMILES: [NH]1C(C(C2C(C(CCC2)C)C)C)CNC1.

About UNSPSC 51361801

UNSPSC 51361801 Dexmedetomidine is a Commodity code that represents pharmaceutical products used in clinical and emergency medical settings, though the recent state and local procurement activity under this code does not align with dexmedetomidine itself — instead, the tagged opportunity reflects broader pharmaceutical and medical supply procurement by state and local health authorities. The scope of work actually being solicited under this code tag involves emergency response medications and related medical systems acquired by county health departments to support community health initiatives and opioid-crisis response programs. State and local issuing bodies using this code include county health departments and county purchasing offices managing health and safety procurements.

Seminole County, Florida posted an IFB (Invitation for Bid) for Naloxone and Drug Deactivation Systems on June 30, 2026, with a response deadline of July 26, 2023 — seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement requires vendors to submit bids through the county's e-Procurement Portal, include all shipping and delivery costs, provide unit pricing for each line item, maintain workers' compensation and commercial general liability insurance, and comply with drug-free workplace and E-Verify requirements. The contract carries an initial two-year term with a one-year renewal option and a three-month probationary period. The solicitation indicates potential FEMA funding, which introduces federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act.

Quick answers

What is UNSPSC 51361801?

UNSPSC 51361801 is Dexmedetomidine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51361801?

UNSPSC 51361801 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51361801

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code